Меню
Идёт набор NCT06875908

Reliability and Validity of the Turkish Version of General Sleep Disturbance Scale (GSDS-T) in Multiple Sclerosis

— Наблюдательное Multiple Sclerosis Sleep Disturbance

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Turkish Validity and Reliability of The GSDS-T in patients with multiple sclerosis.
Кому может быть актуально
Состояния в реестре: Multiple Sclerosis, Sleep Disturbance. Базовые параметры: 18 лет — 65 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Turkey (Türkiye)
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Не всё понятно в терминах? Прочитайте наш гид для пациентов →

Обзор

The GSDS-T was developed by Lee KA to assess difficulty falling asleep, waking up during sleep, sleep quality, and daytime alertnes. The Turkish validity and reliability of the scale have been conducted on stroke patients but not on multiple sclerosis patients. The aim of this study is to investigate the validity and reliability of the Turkish version of general sleep disturbance scale (GSDS-T) in patients with multiple sclerosis

Подробное описание

The GSDS-T was developed by Lee KA to assess difficulty falling asleep, waking up during sleep, sleep quality, and daytime alertnes. The Turkish validity and reliability of the scale has been conducted on stroke patients but not on multiple sclerosis patients. The aim of this study is to investigate the validity and reliability of the Turkish version of general sleep disturbance scale (GSDS-T) in patients with multiple sclerosis. GSD has 21 questions. This study will be conducted on patients with multiple sclerosis (MS). 126 participants will be included in the study. In order to evaluate the validity of the GSDS-T, the Pittsburgh Sleep Quality Index (PSQI) which can evaluate sleep quality and has been validated in Turkish, will be used. Scales will be repeated after 15 days to assess test-retest reliability.

Вмешательства

  • Другое Turkish Validity and Reliability of The GSDS-T in patients with multiple sclerosis
    The aim of this study is to investigate the validity and reliability of the Turkish version of general sleep disturbance scale (GSDS-T) in patients with multiple sclerosis. It has 21 questions. This study will be conducted on patients with multiple sclerosis. In order to evaluate the validity of the GSDS-T, the Pittsburgh Sleep Quality Index (PSQI) which can evaluate sleep quality and has been validated in Turkish, will be used. Scales will be repeated after 15 days to assess test-retest reliabi

Первичные конечные точки

  • Sleep disturbances [Срок оценки: baseline]
  • Sleep quality [Срок оценки: baseline]

Критерии участия

Критерии включения

  • Individuals over the age of 18 who have been diagnosed with Multiple Sclerosis for at least two years,
  • Those with an EDSS score >2.
  • Those without symptoms of insomnia according to the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) diagnostic criteria
  • Individuals whose native language is Turkish and who have the ability to speak and understand.

Критерии исключения

  • Those with severe spasticity,
  • Those with vision and hearing problems,
  • Those with a known mental illness (major depression, schizophrenia, psychosis, etc.),
  • Those in an acute relapse phase,
  • Those using dietary supplements,
  • Those using tranquilizers or immunosuppressants.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Да

Дизайн исследования

Модель наблюдения
Другое

Центры проведения

Turkey (Türkiye) · 1 центр
  • Bağcılar Training and Research Hospital — Bağcılar

Идентификаторы

NCT: NCT06875908 · MS-GSDS

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗